Exponent, Inc. $EXPO Shares Bought by Northwestern Mutual Wealth Management Co.
Northwestern Mutual Wealth Management Co. significantly increased its stake in Exponent, Inc. (EXPO), acquiring 230,072 additional shares in Q4, bringing its total holdings to 230,335 shares valued at approximately $16 million. Despite analysts cutting price targets, the company holds a "Moderate Buy" consensus rating with a $77.50 target. Exponent's latest quarterly earnings surpassed expectations, and it announced a $0.31 per share dividend.
EXPO Technical Analysis | Trend, Signals & Chart Patterns | EXPONENT INC (NASDAQ:EXPO)
This article provides a technical analysis of EXPONENT INC (NASDAQ:EXPO), indicating a poor technical rating of 0 out of 10 and a bearish trend. The stock's performance is below average compared to the overall market and its industry peers, trading in the lower part of its 52-week range. Multiple indicators, including SMA and MACD, signal a negative short and long-term trend, suggesting it may not be an interesting stock for investors at this time.
EXPO (NASDAQ: EXPO) files notice for proposed restricted stock sale
Exponent Inc. (NASDAQ: EXPO) has filed a Form 144 notice with the SEC, indicating proposed sales of restricted common stock. The filing details three lots of restricted shares, totaling 594, 568, and 510 shares, with grant dates spanning from 2021 to 2026. This type of filing informs the market of the intent to sell restricted securities, signaling potential future share availability.
Exponent group VP Richard Reiss sells $98,062 in stock
Exponent Inc.'s Group Vice President, Richard Reiss, sold 1,672 shares of common stock for $98,062 on May 19, 2026. This transaction leaves Reiss with 2,288 shares. The sale occurred as Exponent shares are down 27% year-over-year, despite the company demonstrating a strong financial position, a 13-year dividend increase streak, and solid Q1 2026 earnings that slightly exceeded expectations.
Exponent (NASDAQ: EXPO) VP sells 1,672 shares in open-market trade
Exponent's Group Vice President, Richard Reiss, conducted an open-market sale of 1,672 shares of common stock on May 19, 2026, at an average price of $58.6496 per share. This transaction amounted to approximately $98,062. After the sale, Reiss directly holds 2,288 shares of Exponent common stock.
Exponent group VP Richard Reiss sells $98,062 in stock
Richard Reiss, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 1,672 shares of common stock for $98,062 on May 19, 2026, at a price of $58.6496 per share. Following the sale, Reiss holds 2,288 shares. This insider transaction occurred while Exponent shares are down 27% over the past year, though InvestingPro analysis suggests the stock is undervalued, boasting more cash than debt and 13 consecutive years of dividend increases.
Exponent Inc stock (US30214U1025): earnings resilience and dividend in focus
Exponent Inc (EXPO) has demonstrated resilient financial performance and continues to return capital to shareholders through quarterly dividends, despite its stock price underperforming the broader US market over the past year. The company specializes in high-end engineering and scientific consulting, providing independent technical expertise for complex problems across various sectors. Its project-based model, strong client relationships, and focus on areas like product safety, litigation support, and regulatory compliance are key drivers of revenue and profitability.
Exponent, Inc. $EXPO Shares Sold by Resona Asset Management Co. Ltd.
Resona Asset Management Co. Ltd. reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 5.3% in the fourth quarter, selling 37,176 shares but still holding 668,102 shares valued at $46.8 million. Several corporate insiders, including the VP and CEO, also sold shares recently, totaling 17,026 shares worth about $1.03 million over the past 90 days. Despite some analyst price target reductions, the stock maintains a "Moderate Buy" consensus rating with an average target of $77.50, and the company reported stronger-than-expected quarterly earnings and revenue.
Exponent Inc stock (US30214U1025): insider sale draws attention to engineering consultant
An insider sale by Exponent Inc CEO Catherine Corrigan has brought the engineering consulting firm into focus. The article details Exponent's business model, which involves providing specialized engineering and scientific analysis for corporate, insurance, and government clients, particularly in failure analysis, safety assessments, and litigation support. It also discusses the company's reliance on highly qualified experts, its strong presence in the US market, and the risks associated with talent retention and the episodic nature of litigation work.
Exponent Inc stock (US30214U1025): JP Morgan trims target after CEO share sale and solid earnings
JP Morgan has lowered its price target for Exponent Inc (EXPO) to $80 from $95, while maintaining an Overweight rating, following fresh earnings and a routine share sale by the CEO. The engineering consulting firm recently reported earnings per share slightly above consensus and revenue in line with expectations, demonstrating operational stability. This recalibration of the target, alongside an insider transaction by the CEO, provides a nuanced perspective for investors on the company's valuation and growth outlook.
Exponent president & CEO Catherine Corrigan sells $226,725 of stock
Exponent Inc.'s President and CEO, Catherine Corrigan, sold 4,194 shares of company stock for approximately $226,725 on May 15, 2026. This sale followed the exercise of non-qualified stock options and was primarily to cover the exercise price and taxes. Despite recent stock weakness, the company reported strong first-quarter 2026 earnings, exceeding market expectations.
Exponent (EXPO) CEO sells shares to fund option exercise and taxes
Exponent Inc.'s President & CEO, Catherine Corrigan, exercised options for 5,606 shares and subsequently sold 4,194 shares at an average price of $54.0595 per share on May 15, 2026. These sales were conducted to cover the option exercise price and associated taxes, indicating a routine liquidity event rather than a discretionary sale. Following these transactions, Corrigan directly owns 105,218 shares of Exponent common stock.
4,194-share notice: EXPO (NASDAQ: EXPO) affiliate plans option exercise sale
An affiliate of Exponent Inc. (NASDAQ: EXPO) has filed a Form 144 notice to sell 4,194 shares of Common Stock obtained through the exercise of stock options on May 15, 2026. The filing also details prior 10b5-1 sales by Catherine Corrigan in the preceding three months, involving 3,909, 3,912, and 3,920 shares with reported gross proceeds. This is a routine regulatory notice for an affiliate's proposed resale of securities.
Winners And Losers Of Q1: Exponent (NASDAQ:EXPO) Vs The Rest Of The Business Process Outsourcing & Consulting Stocks
This article analyzes the Q1 performance of business process outsourcing & consulting stocks, focusing on Exponent (EXPO) relative to its peers. While the sector faces both opportunities from digital transformation and challenges from AI and wage inflation, overall Q1 results were mixed, with revenues beating estimates but stock prices generally declining. The article highlights Exponent's revenue growth despite an EPS miss, CBIZ's strong EPS beat, Concentrix's weaker performance, and Aramark's impressive revenue growth.
Kayne Anderson Rudnick holds 3.89M shares of Exponent (EXPO) — 7.9%
Kayne Anderson Rudnick Investment Management, LLC has reported a beneficial ownership of 3,886,546 shares in Exponent Inc (EXPO), which represents a 7.9% stake in the company as of March 31, 2026. This disclosure was made via an amended Schedule 13G/A filing, detailing their sole and shared voting and dispositive powers over these shares. The investment is categorized as a large passive stake by an institutional holder, indicating no intent to influence company control.
Exponent Inc stock (US30214U1025): Executives sell shares amid price drop
Exponent Inc executives Joseph Sala and Joseph Rakow sold a total of over 5,000 shares on May 13, 2026, as the stock experienced a decline of approximately 4.6%. The company, which specializes in engineering and scientific consulting services, primarily generates revenue from US clients and is listed on Nasdaq. These insider sales coincided with a price dip, and investors are advised to monitor SEC filings for future trends.
Exponent Drops 5.5% Amid Sector-Wide Selling
Exponent (EXPO) shares fell 5.5% to $54.03 on May 13, 2026, as part of a broad sector-wide downturn affecting engineering and construction peers. Despite the absence of company-specific news, the synchronized decline, which also impacted SAIC, KBR, HURN, and CBZ, suggests investors are reacting to broader macro factors or shifting sector sentiment. The increased trading volume indicates heightened activity as the selloff unfolded.
What Do Recent Insider Sales at Exponent Inc. (EXPO) Signal to Investors
Recent insider selling at Exponent Inc. by CEO Catherine Corrigan and VP John Pye, totaling over $2.5 million, raises questions despite the company's strong Q1 2026 financial results, which included 14% revenue growth and a 13% EPS increase. Concerns stem from decelerating revenue growth over the past two years, declining free cash flow, and reduced Return on Invested Capital. While analysts maintain a "Strong Buy" rating with a median price target of $90.00, the stock's high forward P/E of 31.8x suggests much of the positive outlook is already priced in, making it vulnerable to any negative surprises.
Insider Sell: Joseph Sala Sells 2,066 Shares of Exponent Inc (EXPO)
Joseph Sala, Group Vice President at Exponent Inc, sold 2,066 shares of the company on May 13, 2026, and now holds no shares. This sale is part of a trend of 14 insider sells and no buys at Exponent Inc over the past year. The stock is currently trading at $56.66, which is significantly undervalued compared to its GF Value of $92.37.
Insider Sell: Joseph Sala Sells 2,066 Shares of Exponent Inc (EXPO)
Joseph Sala, Group Vice President at Exponent Inc (EXPO), sold 2,066 shares of the company on May 13, 2026, leaving him with no shares. This sale is part of a trend of 14 insider sells and zero buys over the past year for Exponent Inc. The stock is currently trading at $56.66 and is considered significantly undervalued with a price-to-GF-Value ratio of 0.61.
Exponent group VP Joseph Rakow sells $160,973 in stock
Joseph Rakow, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 2,945 shares of the company's common stock for $160,973 on May 13, 2026. This transaction leaves him with no shares in the company, amid the stock trading near its 52-week low. Separately, Exponent reported strong first-quarter 2026 earnings, exceeding market expectations with an EPS of $0.57 and revenue of $144.47 million.
Exponent group vice president Sala sells $117,059 in stock
Joseph Sala, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 2,066 shares of the company’s common stock for approximately $117,059. This transaction leaves Mr. Sala with no direct holdings in Exponent. The sale occurred as Exponent shares declined, though the stock is considered undervalued by InvestingPro analysis and the company recently reported strong Q1 2026 earnings.
Exponent (EXPO) Group Vice President sells 2,945 shares in open-market trade
Joseph Rakow, Group Vice President at Exponent Inc. (EXPO), sold 2,945 shares of the company's common stock on May 13, 2026, at an average price of $54.6601 per share in an open-market transaction. Following this sale, Rakow's direct holdings in Exponent common stock are reported as 0 shares. The transaction, categorized as a moderate impact with negative sentiment, was disclosed in a Form 4 SEC filing.
Exponent group VP Joseph Rakow sells $160,973 in stock By Investing.com
Joseph Rakow, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 2,945 shares of the company's common stock for $160,973 on May 13, 2026. This sale leaves Mr. Rakow with no shares in the company, occurring while the stock is near its 52-week low. Despite the recent dip, InvestingPro analysis suggests the stock is undervalued, and the company recently reported strong Q1 2026 earnings that exceeded market expectations.
Exponent Inc (EXPO) Shares Fall 4.6% -- What GF Score of 89 Tells Investors
Exponent Inc (EXPO) saw its shares fall by 4.6% to $54.56, reflecting a significant year-to-date and past-year decline. Despite the drop, its GF Score of 89/100 indicates strong fundamental potential, with the stock being significantly undervalued according to GF Value™. However, recent insider selling and lower momentum scores suggest investors should exercise caution while considering its strong growth and profitability.
Exponent (EXPO) VP Joseph Sala sells 2,066 shares in open-market trade
Exponent Group Vice President Joseph Sala sold 2,066 shares of common stock at $56.66 per share in an open-market transaction on May 13, 2026. This sale, reported in a Form 4 SEC filing, leaves Sala with 0 direct holdings in Exponent common stock. The transaction had a moderate filing impact and negative sentiment, according to the analysis.
[144] EXPONENT INC SEC Filing
Morgan Stanley Smith Barney LLC has filed a Form 144 related to EXPO Common stock, indicating proposed sales of restricted shares totaling 986 shares issued on March 11, 2026, and 1,080 shares issued on March 11, 2022. The filing, dated May 13, 2026, names NASDAQ as the market for these transactions. A securities compliance attorney notes that a Form 144 is an administrative disclosure notifying the market of an affiliate resale under Rule 144.
Truist Financial Corp Cuts Stake in Exponent, Inc. $EXPO
Truist Financial Corp reduced its stake in Exponent, Inc. by 42.8% in the fourth quarter, selling 26,980 shares, though institutional ownership of Exponent remains high at 92.37%. Exponent reported strong quarterly results, exceeding EPS and revenue forecasts, with a 14.3% year-over-year revenue increase. Despite a "Moderate Buy" consensus rating, some analysts have trimmed price targets, and the company recently declared a quarterly dividend of $0.31 per share.
Exponent Drops 5.5% Amid Sector-Wide Selling
Exponent, Inc. (EXPO) saw its shares drop 5.5% to $54.03 on May 13, 2026, as part of a broad downturn affecting the engineering and construction sector. The decline was mirrored by several peers, suggesting a sector-wide pullback rather than company-specific issues for Exponent. Investors are advised to monitor sector stability and any future company updates to assess the situation.
Exponent (NASDAQ: EXPO) CFO reports initial stock, RSU and option holdings
Exponent Inc.'s CFO, Eric R. Anderson, has filed an initial statement of beneficial ownership (Form 3), detailing his holdings in the company. He directly owns 2,955 shares of common stock, along with restricted stock units totaling 14,966 shares (expiring between 2027-2030), and stock options for an additional 12,600 shares with exercise prices of $65.56 and $66.56. This filing indicates an initial establishment of his holdings as CFO and shows no immediate buy or sell transactions.
Exponent stock hits 52-week low at $63.17 By Investing.com
Exponent Inc. (EXPO) stock recently reached a new 52-week low at $62.75, following a 16.5% decline over the past year. Despite this downturn, InvestingPro analysis suggests the stock might be undervalued, with analysts setting price targets between $75 and $95. The company reported strong Q1 2026 earnings, exceeding EPS forecasts, and maintains financial strength with a 1.95% dividend yield, having raised its dividend for 13 consecutive years.
Exponent (NASDAQ: EXPO) grows Q1 2026 revenue 14% and expands buybacks
Exponent, Inc. reported a strong first quarter for 2026, with revenue increasing by 14.3% to $166.3 million and net income rising 11% to $29.6 million. This growth was primarily driven by its Engineering and Other Scientific segment, boosted by AI-related user research and risk management projects. The company also returned capital to shareholders through a $0.31 per-share dividend, $78.8 million in share repurchases, and authorized a new $50 million buyback program.
Exponent (NASDAQ:EXPO) Hits New 12-Month Low - Here's What Happened
Exponent (NASDAQ:EXPO) shares fell to a new 52-week low of $61.43 on Friday, despite the company beating April-quarter earnings and revenue estimates. Analysts have trimmed price targets, yet the stock maintains a "Moderate Buy" consensus rating with an average target of $85. Insiders have also sold shares in recent months.
Vanguard Group Inc. Has $357.23 Million Holdings in Exponent, Inc. $EXPO
Vanguard Group Inc. reduced its stake in Exponent, Inc. by 2.1% in the fourth quarter of 2025, now holding shares valued at $357.23 million. Exponent (NASDAQ:EXPO) reported strong Q1 results, exceeding EPS and revenue expectations. The company also announced a quarterly dividend of $0.31 per share, and institutional investors collectively own 92.37% of its stock.
Forensic Engineering Market Is Going to Boom |• AECOM • Exponent Inc. • RSK Group
Worldwide Market Reports has released an in-depth study on the "Forensic Engineering Market Size and Forecast 2026-2033." The report provides a data-driven evaluation of historical trends, future projections, critical growth drivers, and potential risks, utilizing SWOT analysis and Porter's Five Forces framework. Key players in the market include AECOM, Exponent Inc., and RSK Group, with the market segmented by types such as Civil, Mechanical, and Electrical Engineering, and applications like Structural Failure Analysis and Accident Reconstruction.
Did Strong Q1 Results and Capital Returns Just Shift Exponent's (EXPO) Investment Narrative?
Exponent, Inc. reported robust first-quarter 2026 results, surpassing expectations with strong sales and net income. This performance, coupled with maintained high-single-digit revenue growth guidance and an expanded share repurchase authorization, suggests a positive shift in its investment narrative, emphasizing both growth and capital returns. However, the long-term risk of automation and AI impacting its premium positioning remains a consideration for investors.
Exponent, Inc. $EXPO Stock Holdings Boosted by Fenimore Asset Management Inc
Fenimore Asset Management Inc increased its holdings in Exponent, Inc. (NASDAQ:EXPO) by 17.8% during the fourth quarter, owning 266,892 shares valued at $18.54 million. This comes as Exponent reported strong Q1 results, beating analyst expectations with EPS of $0.59 and revenue of $166.3 million, a 14.3% year-over-year increase. Despite the positive earnings and an announced quarterly dividend of $0.31, the stock traded down approximately 2.4%, with analysts holding a "Moderate Buy" consensus rating and an average price target of $85.
UBS Group Cuts Exponent (NASDAQ:EXPO) Price Target to $75.00
UBS Group has reduced its price target for Exponent (NASDAQ:EXPO) from $85.00 to $75.00, maintaining a "neutral" rating on the stock. This adjustment comes despite Exponent reporting better-than-expected Q1 earnings with EPS of $0.59 and revenue of $166.3 million, and the company increasing its quarterly dividend and share buyback authorization. Insiders have been net sellers, and the stock is currently trading down, with a P/E ratio around 31.
Exponent, Inc. Declares Quarterly Dividend of $0.31 (NASDAQ:EXPO)
Exponent, Inc. (NASDAQ:EXPO) announced a quarterly dividend of $0.31 per share, payable on June 18th to shareholders of record on June 5th. This dividend represents an annual payout of $1.24 per share, resulting in a 1.9% yield, and marks the company's 12th consecutive year of dividend increases. The dividend is well-covered by earnings, with a current payout ratio of 57.9% projected to fall to 48.1% next year based on analyst expectations.
Earnings call transcript: Exponent Q1 2026 sees stock rise post-earnings
Exponent Inc. reported Q1 2026 earnings, with EPS of $0.57 exceeding forecasts and revenue of $144.47 million meeting expectations. The company's stock rose by 1.07% in aftermarket trading, reflecting strong performance driven by AI integration in consumer electronics and increased demand from energy and utility sectors. Exponent's CEO highlighted a strategic focus on innovation, while new President John Pye and CFO Eric Anderson were introduced, signaling a leadership evolution to capitalize on developing market trends.
Conestoga Capital Advisors LLC Buys 31,303 Shares of Exponent, Inc. $EXPO
Conestoga Capital Advisors LLC increased its stake in Exponent, Inc. by 31,303 shares, bringing its total holdings to 2,392,499 shares valued at approximately $166.2 million, making it their 11th largest holding. The increase follows Exponent's strong Q1 results, which beat analyst expectations with $0.59 EPS and $166.3 million in revenue, along with a dividend declaration and an increased stock repurchase authorization. Analysts currently rate Exponent as a "Moderate Buy" with an average target price of $90.00.
Exponent: Q1 Earnings Snapshot
Exponent Inc. (EXPO) reported its first-quarter earnings, totaling $29.6 million, which translates to 59 cents per share. The engineering and scientific consulting company, based in Menlo Park, California, also posted revenue of $166.3 million, with adjusted revenue at $151.8 million. This financial update was provided by Automated Insights, using data from Zacks Investment Research.
Earnings Flash (EXPO) Exponent, Inc. Reports Q1 Revenue $166.3M, vs. FactSet Est of $149.5M
Exponent, Inc. (EXPO) reported its Q1 revenue at $166.3 million, surpassing the FactSet estimate of $149.5 million. The company's stock symbol is EXPO and it is listed on Nasdaq. This news also follows their Q1 EPS report of $0.59, which exceeded the FactSet estimate of $0.57.
Exponent declares $0.31 quarterly dividend, boosts buyback
Exponent, Inc. has announced a quarterly cash dividend of $0.31 per share, payable on June 18, 2026, to stockholders of record as of June 5, 2026. The company also increased its share repurchase authorization by $50 million, bringing the total available for repurchase to $67.7 million. These actions reflect Exponent's commitment to returning capital to shareholders, supported by a history of 13 consecutive years of dividend increases.
Exponent Declares Regular Quarterly Dividend for Q2 2026 and Increases Stock Repurchase Authorization by $50 Million
Exponent (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.31 per share, payable on June 18, 2026, to shareholders of record as of June 5, 2026. Additionally, the company's Board of Directors increased its share repurchase authorization by $50 million, building on the $17.7 million already available. This move reflects Exponent's commitment to returning capital to shareholders, supported by its strong profitability and balance sheet.
Exponent Reports First Quarter 2026 Financial Results
Exponent, Inc. reported strong first-quarter 2026 financial results, with double-digit growth in revenues and earnings driven by increased demand for its specialized expertise in integrating AI into physical products and addressing infrastructure risks. The company achieved $166.3 million in total revenues and a net income of $29.6 million, or $0.59 per diluted share. Exponent also approved an increase in its stock repurchase program and maintains a positive outlook for fiscal year 2026.
[8-K] EXPONENT INC Reports Material Event
Exponent Inc. reported strong first-quarter 2026 financial results, with total revenues increasing 14% to $166.3 million and net income rising to $29.6 million. The company also declared a quarterly dividend of $0.31 per share and increased its stock repurchase authorization by $50 million, signaling continued capital returns to shareholders. Exponent maintained its full-year 2026 guidance for high-single-digit revenue growth and strong EBITDA margins, driven by demand for its specialized expertise in evolving markets.
Exponent earnings on deck as revenue growth question looms
Exponent Inc. is set to release its first-quarter fiscal 2026 results, with analysts expecting earnings of 57 cents per share on revenue of $144.5 million, reflecting a slight revenue decline but increased EPS. Investors are keenly watching the company's revenue trajectory, particularly in utilities and consumer electronics, and its ability to maintain profitability ahead of a leadership transition. The stock is currently rated a Buy with a mean price target of $90, indicating a potential 36% upside.
Vanguard holds 2.59M Exponent shares (EXPO) in Schedule 13G snapshot
Vanguard Capital Management reported a beneficial ownership of 2,586,291 shares, representing 5.25% of Exponent Inc.'s (EXPO) common stock, as detailed in a Schedule 13G filing effective March 31, 2026. This passive investment disclosure indicates Vanguard's sole dispositive power over all 2.59 million shares and sole voting power over 375,641 shares. The filing aggregates holdings across various Vanguard funds and managed accounts, clarifying the ownership structure.
Vanguard Portfolio Management (EXPO) holds 2.99M shares, 6.07% stake
Vanguard Portfolio Management has reported a 6.07% stake in Exponent Inc (EXPO), holding 2,990,195 shares as of March 31, 2026. This ownership was disclosed via a Schedule 13G SEC filing, indicating Vanguard holds sole voting power over 43,439 shares and sole dispositive power over all 2,990,195 shares. The filing specifies that these holdings are for Vanguard funds and managed accounts, signifying passive institutional ownership rather than an active control intent.
